Session Details

Cancer Clinical / Diagnostic Aspects

Wednesday, 24 March 2004 08:30 -10:00

Co-Chair Nils Brünner Royal Veterinary and Agricultural University & Hvidovre Hospital, CopenhagenDenmark
Co-Chair Hein W Verspaget Leiden University Medical CenterThe Netherlands

Development of Peptidomimetic Inhibitors of Matriptase, a Serine Protease Involved in Extracellular Matrix Remodelling, Tumor Growth and Metastasis
  • Dr Joerg Stuerzebecher, University of Jena, Germany
  • Novel and Specific 4-amidinobenzylamine-based Inhibitors of Urokinase
  • Dr Torsten Steinmetzer, Curacyte Chemistry GmbH, Germany
  • The Associations between Plasminogen Activator Inhibitor-1, Urokinase-like Plasminogen Activator and Receptor Levels with Survival Outcome in Ovarian Cancer
  • Stephen CL Koh, National University of SIngapore, Singapore
  • Integration of uPA, uPAR & PAI-1 and Gene Expression Profiles of Human Breast Cancer Cells Procured by Laser Capture Microdissection
  • James L Wittliff, University of Louisville, United States
  • A Novel Non-invasive Diagnostic Imaging Technique of Metastatic Cancer using PAI-2
  • Dr Marie Ranson, University of Wollongong, Australia
  • High Post-operative Plasma Levels of Tissue Inhibitor of Metalloproteinases 1 in Colorectal Cancer Patients are Indicative of Minimal Residual Disease
  • Nils Brünner, Royal Veterinary and Agricultural University & Hvidovre Hospital, Copenhagen, Denmark